RBN-012811

N/A

Report date: 2023/03/07 15:35:59
NME

Base Information

Drug NameRBN-012811
Drug Alias NameRBN 012811RBN-012811
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionPoly(ADP-Ribose) Polymerase 14 degraders
TargetsPoly(ADP-Ribose) Polymerase 14
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRibon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRibon Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A